鼻咽癌
溶解循环
爱泼斯坦-巴尔病毒
癌症研究
生物
基因表达
分子生物学
病毒
免疫学
基因
医学
内科学
遗传学
放射治疗
作者
Chung-Chun Wu,Mei‐Shu Chen,Ting-Ying Lee,Tze‐Sing Huang,Der‐Yang Cho,Jen‐Yang Chen
出处
期刊:Viral Immunology
[Mary Ann Liebert, Inc.]
日期:2024-03-01
卷期号:37 (2): 115-123
被引量:7
标识
DOI:10.1089/vim.2023.0118
摘要
Nasopharyngeal carcinoma (NPC) is a specific human malignancy with unique geographic distribution and genetic backgrounds. Although early treatment with radio-chemotherapy has been proven effective for NPC therapy, its therapeutic efficacy substantially diminishes in the late stages of this malignancy. In the tumor microenvironment of NPC, PD-L1 has been demonstrated as a critical factor in impairing T cell activation. As an etiological role for NPC development, it is found that Epstein-Barr virus (EBV) latent proteins upregulated PD-L1 expression. However, whether EBV lytic protein affects PD-L1 expression remains unclear. In this study, through monitoring the mRNA expression pattern of lytic genes and PD-L1 in EBV-positive NPC cell line NA, EBV immediately-early gene BRLF1(Rta) was found to have the potential for PD-L1 activation. Furthermore, we identified that Rta expression enhanced PD-L1 expression in mRNA and protein levels through quantitative real-time polymerase chain reaction and western blotting analysis. The luciferase reporter assay revealed that Rta expression enhanced PD-L1 promoter activity. We also demonstrated that Rta-induced PD-L1 expressions could impair interleukin 2 secretion of T cells, and this mechanism may be through ERK activation. These results displayed the importance of EBV Rta in PD-L1 expression in NPC and may give an alternative target for NPC therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI